Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans

Growth Hormone and IGF Research

Volumn 22, Issue 2, 2012, Pages 64-68

  Nishizawa, Hitoshi ^a   Handayaningsih, Anastasia Evi ^a   Iguchi, Genzo ^a   Cho, Yoshitake ^b   Takahashi, Michiko ^a   Yamamoto, Masaaki ^a   Suda, Kentaro ^a   Kasahara, Kohei ^b   Hakuno, Fumihiko ^b   Yamanouchi, Keitaro ^b   Nishihara, Masugi ^b   Seino, Susumu ^a   Takahashi, Shin Ichiro ^b   Takahashi, Yutaka ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Acromegaly; GH transgenic rat; IGF I; Oxidative stress; Reactive oxygen species; ROS

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GROWTH HORMONE; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACROMEGALY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TISSUE INJURY; TISSUE LEVEL; VASCULAR SMOOTH MUSCLE;

ACROMEGALY; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MUSCLE CELLS; OXIDATIVE STRESS; OXYGEN; PREVALENCE; RATS; REACTIVE OXYGEN SPECIES;

EID: 84859157052     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.02.001     Document Type: Article

References (36)

1. Melmed S. Medical progress: acromegaly. N. Engl. J. Med. 2006, 355:2558-2573.
2. Colao A. The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin. Endocrinol. (Oxf) 2008, 69:347-358.
3. Clayton R.N. Cardiovascular function in acromegaly. Endocr. Rev. 2003, 24:272-277.
4. Biermasz N.R., Dekker F.W., Pereira A.M., van Thiel S.W., Schutte P.J., van Dulken H., Romijn J.A., Roelfsema F. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J. Clin. Endocrinol. Metab. 2004, 89:2789-2796.
5. Swearingen B., Barker F.G., Katznelson L., Biller B.M., Grinspoon S., Klibanski A., Moayeri N., Black P.M., Zervas N.T. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83:3419-3426.
6. Ayuk J., Clayton R.N., Holder G., Sheppard M.C., Stewart P.M., Bates A.S. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J. Clin. Endocrinol. Metab. 2004, 89:1613-1617.
7. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
8. Kondo T., Hirose M., Kageyama K. Roles of oxidative stress and redox regulation in atherosclerosis. J. Atheroscler. Thromb. 2009, 16:532-538.
9. Adiga I.K., Nair R.R. Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem. Funct. 2008, 26:346-351.
10. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
11. Adachi T., Togashi H., Suzuki A., Kasai S., Ito J., Sugahara K., Kawata S. NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 2005, 41:1272-1281.
12. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 1997, 272:217-221.
13. Mahadev K., Wu X., Zilbering A., Zhu L., Lawrence J.T., Goldstein B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 2001, 276:48662-48669.
14. Meng D., Shi X., Jiang B.H., Fang J. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 2007, 42:1651-1660.
15. Meng D., Lv D.D., Fang J. Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc. Res. 2008, 80:299-308.
16. Fukuoka H., Iida K., Nishizawa H., Imanaka M., Takeno R., Iguchi G., Takahashi M., Okimura Y., Kaji H., Chihara K., Takahashi Y. IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes. Growth Horm. IGF Res. 2010, 20:212-219.
17. Handayaningsih A.E., Iguchi G., Fukuoka H., Nishizawa H., Takahashi M., Yamamoto M., Herningtyas E.H., Okimura Y., Kaji H., Chihara K., Seino S., Takahashi Y. Reactive oxygen species play an essential role in IGF-I signaling and IGF-I-induced myocyte hypertrophy in C2C12 myocytes. Endocrinology 2011, 152:912-921.
18. Cho Y., Ariga M., Uchijima Y., Kimura K., Rho J.Y., Furuhata Y., Hakuno F., Yamanouchi K., Nishihara M., Takahashi S. The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats. Endocrinology 2006, 147:5374-5384.
19. Melmed S., Colao A., Barkan A., Molitch M., Grossman A.B., Kleinberg D., Clemmons D., Chanson P., Laws E., Schlechte J., Vance M.L., Ho K., Giustina A. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 2009, 94:1509-1517.
20. Takahashi Y., Iida K., Takahashi K., Yoshioka S., Fukuoka H., Takeno R., Imanaka M., Nishizawa H., Takahashi M., Seo Y., Hayashi Y., Kondo T., Okimura Y., Kaji H., Kitazawa R., Kitazawa S., Chihara K. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology 2007, 132:938-943.
21. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27:612-616.
22. Segard H.B., Moulin S., Boumard S., Augier de Cremiers C., Kelly P.A., Finidori J. Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts. Cell. Signal. 2003, 15:615-623.
23. Sadowski C.L., Wheeler T.T., Wang L.H., Sadowski H.B. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 2001, 142:3890-3900.
24. Boero L., Cuniberti L., Magnani N., Manavela M., Yapur V., Bustos M., Rosso L.G., Merono T., Marziali L., Viale L., Evelson P., Negri G., Brites F. Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly. Clin. Endocrinol. (Oxf) 2010, 72:654-660.
25. Andersson I.J., Johansson M.E., Wickman A., Bohlooly Y.M., Klintland N., Caidahl K., Gustafsson M., Boren J., Gan L.M., Bergstrom G. Endothelial dysfunction in growth hormone transgenic mice. Clin. Sci. (Lond.) 2006, 110:217-225.
26. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23:599-622.
27. Powers R.W., Majors A.K., Lykins D.L., Sims C.J., Lain K.Y., Roberts J.M. Plasma homocysteine and malondialdehyde are correlated in an age- and gender-specific manner. Metabolism 2002, 51:1433-1438.
28. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 2003, 23:434-439.
29. Rahman I., MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic. Biol. Med. 1996, 21:669-681.
30. Sugamura K., Keaney J.F. Reactive oxygen species in cardiovascular disease. Free Radic. Biol. Med. 2011, 51:978-992.
31. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
32. West I.C. Radicals and oxidative stress in diabetes. Diabet. Med. 2000, 17:171-180.
33. Hulsmans M., Holvoet P. The vicious circle between oxidative stress and inflammation in atherosclerosis. J. Cell. Mol. Med. 2010, 14:70-78.
34. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
35. Colao A., Spiezia S., Cerbone G., Pivonello R., Marzullo P., Ferone D., Di Somma C., Assanti A.P., Lombardi G. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin. Endocrinol. (Oxf) 2001, 54:515-524.
36. Papaconstantinou J. Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Mol. Cell. Endocrinol. 2009, 299:89-100.